Trial
NCT03004443
Inflammation-Induced CNS Glutamate Changes in Depression
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
National Institute of Mental Health (NIMH)
Condition
Depression
Intervention
Infliximab
Why stopped
The study was suspended in March 2020 due to the COVID-19 pandemic and ultimately was terminated as it is not safe to test a potent anti-inflammatory drug with ongoing surges of COVID-19.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-27